Whitepaper
6 Oct 2020

Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs through Process Engineering and Technological Innovation

PDF 145 kB

This case study presents the successful collaboration between an early-stage company that was struggling with the development of a realistic and economically viable commercial pathway and BioVectra, a CDMO with 50 years of experience.

Content provided by our supplier

BioVectra Inc.

  • CA
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator

Other Content from BioVectra Inc. (2)